Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -111.26% is in line with its 5-year average of -106.52%, around the middle of its 5-year range (-181.91%–-53.64%).
24.53% above its 12-month average of -147.41%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-06-30): -24.82%.
RETURN ON ASSETS (ROA)
-111.26%
RETURN ON ASSETS (ROA) AVG TTM
-147.41%
RETURN ON ASSETS (ROA) AVG 3Y
-127.90%
RETURN ON ASSETS (ROA) AVG 5Y
-106.52%
RETURN ON ASSETS (ROA) AVG 10Y
-140.00%
RETURN ON ASSETS (ROA) AVG 15Y
-361.20%
RETURN ON ASSETS (ROA) AVG 20Y
-430.06%
CURRENT VS TTM AVG
+24.53%
CURRENT VS 3Y AVG
+13.01%
CURRENT VS 5Y AVG
-4.44%
CURRENT VS 10Y AVG
+20.53%
CURRENT VS 15Y AVG
+69.20%
CURRENT VS 20Y AVG
+74.13%
SECTOR MEDIAN · HEALTHCARE
-26.90%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-313.61%
vs the sector median at left
Aethlon Medical, Inc.
Market Cap
$3.34M
Return on Assets (ROA)
-111.26%
TTM Avg
-147.41%
3Y Avg
-127.90%
5Y Avg
-106.52%
Market Cap
$3.47M
Return on Assets (ROA)
-95.33%
TTM Avg
-115.11%
3Y Avg
-93.94%
5Y Avg
-73.81%
Market Cap
$3.48M
Return on Assets (ROA)
-67.51%
TTM Avg
-41.84%
3Y Avg
-44.47%
5Y Avg
-41.13%
Market Cap
$3.37M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.07M
Return on Assets (ROA)
-80.08%
TTM Avg
-84.48%
3Y Avg
-250.02%
5Y Avg
-187.49%
Market Cap
$3.09M
Return on Assets (ROA)
-238.27%
TTM Avg
-211.11%
3Y Avg
-146.32%
5Y Avg
-173.65%
Market Cap
$3.98M
Return on Assets (ROA)
-181.89%
TTM Avg
-125.13%
3Y Avg
-74.22%
5Y Avg
-63.39%
Market Cap
$4.18M
Return on Assets (ROA)
N/A
TTM Avg
-140.48%
3Y Avg
-390.49%
5Y Avg
-423.69%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aethlon Medical, Inc. (AEMD) | $3.34M | -111.26% | -147.41% | -127.90% | -106.52% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -95.33% | -115.11% | -93.94% | -73.81% |
| Evogene Ltd. (EVGN)vs › | $3.48M | -67.51% | -41.84% | -44.47% | -41.13% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | -206.55% | -205.58% | -343.02% | -343.02% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -80.08% | -84.48% | -250.02% | -187.49% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -238.27% | -211.11% | -146.32% | -173.65% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | -181.89% | -125.13% | -74.22% | -63.39% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | -140.48% | -390.49% | -423.69% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -154.47% | -121.84% | -88.87% | -75.91% |
ROA
-111.3%
ROE
-133.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -112.92% |
| 2025-03-31 | -181.91% |
| 2024-03-31 | -148.05% |
| 2023-03-31 | -68.71% |
| 2022-03-31 | -53.64% |
| 2021-03-31 | -73.92% |
| 2020-03-31 | -61.36% |
| 2019-03-31 | -150.26% |
| 2018-03-31 | -77.26% |
| 2017-03-31 | -421.46% |
| 2016-03-31 | -190.55% |
| 2015-03-31 | -492.33% |
| 2014-03-31 | -787.98% |
| 2013-03-31 | -984.91% |
| 2012-03-31 | -967.10% |
| 2011-03-31 | -1006.84% |
| 2010-03-31 | -707.89% |
| 2009-03-31 | -3082.25% |
| 2008-03-31 | -848.18% |
| 2007-03-31 | -982.30% |
| 2006-03-31 | -283.56% |
| 2005-03-31 | -698.18% |
| 2004-03-31 | -539.30% |
| 2003-03-31 | -617.53% |
| 2002-03-31 | -410.46% |
| 2001-03-31 | -344.49% |
| 2000-03-31 | -98.41% |
| 1999-03-31 | -429.71% |
| 1998-03-31 | -65235.01% |
| 1997-03-31 | -56.31% |
